The National Cancer Institute awards $397,000 grant to Precision Epigenomics

February 1, 2022 – The National Cancer Institute awards a $397,000 NIH SBIR Phase I project to Precision Epigenomics titled: Lung Cancer, DNA Methylation, and Liquid Biopsy.

Precision Epigenomics is highlighted at University of Arizona Research Day

April 2021 – Precision Epigenomics Inc was selected to present their findings regarding the development of a liquid biopsy assay for non-small cell lung to the leadership and faculty of the University of Arizona.

August 2020 – Precision Epigenomics was chosen by the Town of Sahuarita for sponsorship in the Bizlaunch program run by the University of Arizona Center for Innovation (UACI). The Bizlaunch program is funded by the Town of Sahuarita and Freeport-McMoRan. Precision Epigenomics was chosen because of our connection to the town, the benefit of our technology to the community and globe, and innovation.